Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1-2
|
pubmed:dateCreated |
1997-5-22
|
pubmed:abstractText |
Mutant viruses with deletions in genes encoding non-essential glycoproteins are considered as promising bovine herpesvirus 1 (BHV1) vaccine candidates. The present study compared the influence of various gene deletions (gC, gE, gI, gG) on the induction of cell-mediated immune responses against the virus. The highest BHV1 specific lymphoproliferative response was observed in the group of calves inoculated with the gC- mutant. However, in all groups of inoculated calves, limiting dilution analysis showed marked individual variability in the number of BHV1 specific T lymphocytes that were stimulated. The same animals were then challenged with wild-type BHV1. In these animals, limiting dilution analysis did not reveal gE, gI nor gG as a major T lymphocyte antigen. However, further analysis suggested the T cell antigenicity of gE in a low number of BHV1 hyperimmunized calves. Stimulation of MHC unrestricted cytotoxicity was also evaluated after inoculation with the various deletion mutants. Cytotoxicity in gC- inoculated calves was as high as in BHV1 inoculated calves. In conclusion, among the BHV1 deletion mutants that were tested, the gC- mutant stimulated the best cell-mediated immune responses.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Vaccines, Synthetic,
http://linkedlifedata.com/resource/pubmed/chemical/Viral Envelope Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Viral Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Viral Vaccines,
http://linkedlifedata.com/resource/pubmed/chemical/bovine herpesvirus type-1...
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0378-1135
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
53
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
121-32
|
pubmed:dateRevised |
2008-8-30
|
pubmed:meshHeading |
pubmed-meshheading:9011004-Animals,
pubmed-meshheading:9011004-Cattle,
pubmed-meshheading:9011004-Cattle Diseases,
pubmed-meshheading:9011004-Cytotoxicity, Immunologic,
pubmed-meshheading:9011004-Herpesviridae Infections,
pubmed-meshheading:9011004-Herpesvirus 1, Bovine,
pubmed-meshheading:9011004-Immunity, Cellular,
pubmed-meshheading:9011004-Lymphocyte Activation,
pubmed-meshheading:9011004-Lymphocytes,
pubmed-meshheading:9011004-Mutagenesis,
pubmed-meshheading:9011004-Sequence Deletion,
pubmed-meshheading:9011004-Vaccines, Synthetic,
pubmed-meshheading:9011004-Viral Envelope Proteins,
pubmed-meshheading:9011004-Viral Proteins,
pubmed-meshheading:9011004-Viral Vaccines
|
pubmed:year |
1996
|
pubmed:articleTitle |
The role of glycoproteins gC, gE, gI, and gG in the induction of cell-mediated immune responses to bovine herpesvirus 1.
|
pubmed:affiliation |
Dept. of Virology and Immunology, Faculty of Veterinary Medicine, University of Liège, Belgium.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|